Bioton
company
Warsaw SE
ISIN PLBIOTN00029 LEI 259400I5R1L3OPCGII81
Follow Bioton
Weekly email: filings, results
Revenue, last year
PLN 233.2M
+43% vs prior year
Net income
PLN 1.4M
−50.7% vs prior year
EPS, diluted
-
Operating cash flow
PLN 56.1M
+915.6% vs prior year
Source: ESEF annual reports · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY22 | PLN 233.2M | PLN 1.4M |
| FY21 | PLN 163M | PLN 2.9M |
| FY20 | PLN 221.8M | PLN 33.9M |
| FY19 | PLN 202M | −PLN 126.7M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY22 | 41.1% | 9.1% | 0.6% |
| FY21 | 47.7% | 8.8% | 1.8% |
| FY20 | 47.2% | 21.9% | 15.3% |
| FY19 | 50.6% | 80.9% | −62.7% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY22 | PLN 26.5M |
| FY21 | −PLN 7.4M |
| FY20 | PLN 37.3M |
| FY19 | −PLN 6.7M |
- Bioton
- Healthcare median
Show the numbers
| Year | Bioton | Healthcare median |
|---|---|---|
| FY22 | 0.6% | −80.4% |
| FY21 | 1.8% | −71.9% |
| FY20 | 15.3% | −62.2% |
| FY19 | −62.7% | −46.3% |